DOI QR코드

DOI QR Code

Epidemiologic Characteristics of Death in Breast Cancer Patients and Health Promotion Plans : Using Korean Cancer Registry data

유방암 환자 사망의 역학적 특성과 건강증진 방안 : 국가 암등록 자료를 이용하여

  • Young-Hee Nam (Dept. of Health Administration, Namseoul University)
  • 남영희 (남서울대학교 보건행정학과)
  • Received : 2023.02.01
  • Accepted : 2023.02.25
  • Published : 2023.02.28

Abstract

Objectives: The purpose of this study was to identify the major influencing factors of breast cancer death and to suggest policy measures to promote the health of breast cancer patients. Methods: The method of this study performed statistical analysis by applying weights to 2,300 cases of breast cancer registration statistics in Korea collected in 2018 due to the relatively small number of mortality data compared to survival. Statistical processing of the collected data was analyzed using SPSS 26.0. Results: The epidemiologic characteristics of death in breast cancer patients were 31.8% in those aged 70 years or older, and the mortality rate was 5.25 times higher in patients aged 70 years or older than those aged 39 years or younger. The anatomical site code was 36.4% in C50.4~C50.6, and the mortality rate was 1.82 times higher in C50.4~C50.6 than in C50.0~C50.1. The tumor size was 40.4% and larger than 4cm, and the mortality rate was 4.53 times higher in tumors larger than 4cm than those smaller than 1cm. The degree of differentiation was 13.9% in the poorly differentiated group, and the mortality rate was 4.38 times higher in the poorly differentiated group than in the highly differentiated group. In the hormone receptor test, non-triple negative cases were 59.6%, and the mortality rate was 0.57 times lower in non-triple negative cases than in triple negative cases. As for lymph node involvement, the presence or absence of lymph node involvement was 78.8%, and the mortality rate with lymph node involvement was 1.36 times higher than that without lymph node involvement. The survival period of 13 to 24 months was the highest at 26.5%, and the average survival period was 25.68 months (±14.830). Conclusion: A policy to advance the timing of national health examinations for early detection of breast cancer is necessary. In addition, a bill for the mandatory placement of health educators in medical institutions for patients with special diseases such as breast cancer should be prepared.

Keywords

Acknowledgement

이 논문은 2022년도 남서울대학교 교내학술연구비 지원에 의해 연구되었음.

References

  1. 강선희, 조지형. (2011). 1cm 이하의 침윤성 유방암 환자에서 겨드랑이 림프절 전이에 대한 예측인 자. 대한외과학회지, 80(1), 10-15. DOI: 10.4174/jkss.2011.80.1.10 
  2. 강은영, 한상아, 김새리, 김선미, 장미정 등. (2010). 신생병원의 5년 유방암 치료 경험: 임상데이터웨어하우스를 이용한 분석. Journal breast cancer, 13(1), 96-103. DOI: 10.4048/jbc.2010.13.1.96 
  3. 국가암정보센터, https://www.cancer.go.kr/lay1/S1T645C647/contents.do, 2023.0212. searched. 
  4. 국어사전. (2023). https://wordrow.kr, 2023.1.26. 검색 
  5. 김영훈, 김유석. (2022). 유방암에서 수술 전 초음파, 자기공명영상과 병리검사 크기의 비교. J Surg Ultrasound, 9(2), 18-21. https://doi.org/10.46268/jsu.2022.9.1.18 
  6. 모은희, 임청환, 이상호, 정홍량, 이혜남. (2011). 유방암 환자를 대상으로 한 유방영상검사 분석. 방사선기술과학, 34(1), 1-7. 
  7. 민병삼, 위희수, 김재선, 임동수. (1996). 유방암의 임상분석. 대한외과학회지, 50(2), 202-209. 
  8. 박수경, 강대희, 김연주, 유근영. (2009). 한국인 유방암의 역학적 특성. 대한의사협회지, 52(10), 937-945. 
  9. 보건복지부, 중앙암등록본부. (2022). 2020년 국가암등록통계.
  10. 보건복지부. (2022). 2020년 암등록통계 및 2014-2018 지역별 암발생통계 보도자료, 국립암 센터.
  11. 안재석, 조지형, 권선영, 강선희. (2009). 조기 유방암에서 삼중복 음성군의 임상 병리학적 특징 및 예후: 비삼중복 음성 유방암과 비교. 대한외과학회지, 77(1), 37-42. DOI: 10.4174/jkss.2009.77.1.37 
  12. 이경근, 김진영, 정진향, 박지영, 박호용. (2010). 삼중음성유방암과 비삼중음성유방암의 임상병리 학적 특성의 비교. 대한외과학회지, 79(1), 14-19. DOI: 10.4174/jkss.2010.79.1.14 
  13. 이수현, 문우경. (2022). 유방암의 역학 및 검진. 대한유방검진의학회지, 19, 1-15. 
  14. 최지현. (2020). 생존분석을 통한 구직기간 결정 요인 연구. 한국노동패널학술대회, 한국노동연구원, 311-342. 
  15. 통계청. (2022). 사망원인별 사망자수, 사망률 통계, https://kosis.kr/ 
  16. 한국유방건강재단. (2023). https://www.kbcf.or.kr/bhi/bhi_info/present/death_rate_foreign.do, 2023. 01. 26. searched. 
  17. Kaplan, E. L., Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American statistical association, 53(282), 457-481.  https://doi.org/10.1080/01621459.1958.10501452
  18. Ko SS. (2008). Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years(1996-2006) using nationwide breast cancer registration online program: biannual update. J Surg Oncology, 98, 318-323. DOI: 10.1002/jso.21110 
  19. Qiu J., Xue X., Hu C., Xu H., Kou D., et a;. (2016). Comparison of clinicopathological features and prognosis in triple-negative and non-triple negative breast cancer. Journal of cancer, 7(2), 167-173. doi: 10.7150/jca.10944 
  20. Siotos C., McColl M., Psoter K., Gilmore R. C., Sebai M. E., et al. (2018). Tumor Site and Breast Cancer Prognosis, Clinical Breast Cancer, 18(5), e1045-e1052. https://doi.org/10.1016/j.clbc.2018.05.007 
  21. Sung H, Ferlay J, Siegel RL, et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 71, 209-249.  https://doi.org/10.3322/caac.21660
  22. Yoo KY, Kim Y, Park SK, Kang D. (2006). Lifestyle, genetic susceptibility and future trends of breast cancer in Korea. Asian Pac J Cancer Prev, 7(4), 679-682.